Entries of von Baumgarten, Louisa on the publication server

Weidner, Lorraine, Lorenz, Julia, Quach, Stefanie, Braun, Frank K., Rothhammer-Hampl, Tanja, Ammer, Laura-Marie, Vollmann-Zwerenz, Arabel, Bartos, Laura M., Dekorsy, Franziska J., Holzgreve, Adrien, Kirchleitner, Sabrina V. , Thon, Niklas, Greve, Tobias, Ruf, Viktoria, Herms, Jochen, Bader, Stefanie, Milenkovic, Vladimir M., von Baumgarten, Louisa, Menevse, Ayse N., Hussein, Abir , Sax, Julian, Wetzel, Christian H. , Rupprecht, Rainer, Proescholdt, Martin A., Schmidt, Nils O., Beckhove, Philipp, Hau, Peter, Tonn, Joerg-Christian, Bartenstein, Peter, Brendel, Matthias, Albert, Nathalie L. and Riemenschneider, Markus J. (2023) Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophages. Acta Neuropathologica Communications 11 (1).

Zounek, Adrian Jun, Albert, Nathalie Lisa, Holzgreve, Adrien, Unterrainer, Marcus, Brosch-Lenz, Julia, Lindner, Simon, Bollenbacher, Andreas, Boening, Guido, Rupprecht, Rainer, Brendel, Matthias, von Baumgarten, Louisa, Tonn, Joerg-Christian, Bartenstein, Peter, Ziegler, Sibylle and Kaiser, Lena (2023) Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas. Zeitschrift für Medizinische Physik 33 (1), pp. 91-102. Fulltext not available.

Albert, Nathalie L., Nelwan, Debie V., Fleischmann, Daniel F., Quach, Stefanie, von Rohr, Katharina, Kaiser, Lena, Teske, Nico, Unterrainer, Lena M., Bartos, Laura M., Ruf, Viktoria C., Brendel, Matthias, Riemenschneider, Markus J., Wetzel, Christian , Herms, Jochen, Rupprecht, Rainer, Thon, Niklas, Tonn, Joerg-Christian, Belka, Claus, Bartenstein, Peter, von Baumgarten, Louisa, Niyazi, Maximilian , Unterrainer, Marcus and Holzgreve, Adrien (2023) Prognostic Value of TSPO PET Before Radiotherapy in Newly Diagnosed IDH–Wild-Type Glioblastoma. Journal of Nuclear Medicine 64 (10), pp. 1519-1525. Fulltext not available.

Bartos, Laura M., Kirchleitner, Sabrina V. , Blobner, Jens, Wind, Karin, Kunze, Lea H., Holzgreve, Adrien, Gold, Lukas, Zatcepin, Artem , Kolabas, Zeynep Ilgin, Ulukaya, Selin , Weidner, Lorraine, Quach, Stefanie, Messerer, Denise, Bartenstein, Peter, Tonn, Joerg C., Riemenschneider, Markus J., Ziegler, Sibylle, von Baumgarten, Louisa, Albert, Nathalie L. and Brendel, Matthias (2022) 18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse model. Frontiers in Medicine 9. Fulltext not available.

Kaiser, Lena , Holzgreve, Adrien, Quach, Stefanie, Ingrisch, Michael, Unterrainer, Marcus, Dekorsy, Franziska J., Lindner, Simon, Ruf, Viktoria, Brosch-Lenz, Julia, Delker, Astrid, Böning, Guido, Suchorska, Bogdana, Niyazi, Maximilian, Wetzel, Christian H. , Riemenschneider, Markus J., Stöcklein, Sophia, Brendel, Matthias, Rupprecht, Rainer, Thon, Niklas, von Baumgarten, Louisa, Tonn, Jörg-Christian, Bartenstein, Peter, Ziegler, Sibylle and Albert, Nathalie L. (2021) Differential Spatial Distribution of TSPO or Amino Acid PET Signal and MRI Contrast Enhancement in Gliomas. Cancers 14 (1), p. 53. Fulltext not available.

Niyazi, Maximilian, Harter, Patrick N. , Hattingen, Elke , Rottler, Maya, von Baumgarten, Louisa, Proescholdt, Martin, Belka, Claus, Lauber, Kirsten and Mittelbronn, Michel (2016) Bevacizumab and radiotherapy for the treatment of glioblastoma: brothers in arms or unholy alliance? Oncotarget 7 (3). Fulltext not available.

Illerhaus, Gerald, Kasenda, Benjamin, Ihorst, Gabriele, Egerer, Gerlinde, Lamprecht, Monika, Keller, Ulrich, Wolf, Hans-Heinrich, Hirt, Carsten, Stilgenbauer, Stephan, Binder, Mascha, Hau, Peter, Edinger, Matthias , Frickhofen, Norbert, Bentz, Martin, Möhle, Robert, Röth, Alexander, Pfreundschuh, Michael, von Baumgarten, Louisa, Deckert, Martina, Hader, Claudia, Fricker, Heidi, Valk, Elke, Schorb, Elisabeth, Fritsch, Kristina and Finke, Jürgen (2016) High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. The Lancet Haematology 3 (8), e388-e397. Fulltext not available.